The Advisory Board at Enalare Therapeutics comprises a select group of experts who provide strategic guidance and scientific insight to advance the development of novel therapies for acute respiratory and critical care conditions. This team plays a crucial role in advising on clinical study designs, regulatory strategies, and broader scientific initiatives, ensuring that the company's innovative approaches align with best practices and the latest research advancements.
Albert Dahan
Scientific Advisory Board
Alexander Kraus
Scientific Advisory Board
Bob Yedid
Independent Director
David Battleman
Scientific Advisory Board
Eugene Vortsman
Scientific Advisory Board
Gino Santini
Independent Director
Joseph Petko
Independent Director
Mark Coleman
Independent Director
Tj Gan
Scientific Advisory Board
View all